NEW YORK (GenomeWeb) – Life science omics tools and molecular diagnostics stocks eked out a small gain in July lifted by the relative strength of the broader biotechnology space. 

The GenomeWeb Index rose a fraction of 1 percent compared to June, as 17 companies saw gains in their share prices while 15 firms saw declines in their stocks. The index beat the Dow Jones Industrial Average, which improved a fraction of 1 percent, but it trailed the Nasdaq, which was up about 3 percent, and the Nasdaq Biotech Index, which grew almost 4 percent. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.